Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PhotoMedex Inc (NASDAQ:PHMD)

Delayed Data
As of 3:59pm ET
 +0.0277 / +6.41%
Today’s Change
Today|||52-Week Range
Health Technology
Medical Specialties

Company Description

PhotoMedex, Inc. is a global skin health company, which provides integrated disease management and aesthetic solutions to dermatologists, professional aestheticians and consumers. It provides proprietary products and services that address skin diseases and conditions including psoriasis, vitiligo, acne, actinic keratosis and photo damage. The company operates through three segments: Consumer segment, Physician Recurring segment and Professional segment. The Consumer segment designs, develops, manufactures and sells long-term hair reduction and acne consumer products. The Physician recurring segment sales entail those generated under two of its product lines: the XTRAC, a noninvasive, FDA-cleared solution for psoriasis and vitiligo, and the NEOVA, a topical therapy combining DNA repair enzymes and copper peptide complexes to prevent premature skin aging, product lines. The Professional segment sells lasers, medical and esthetic light and heat based products and LED products. The company was founded on December 12, 2010 and is headquartered in Montgomeryville, PA.

Contact Information

PhotoMedex, Inc.
100 Lakeside Drive
Horsham Pennsylvania 19044
P:(215) 619-3600
Investor Relations:



Mutual fund holders8.06%
Individual stakeholders30.72%
Other institutional29.17%

Top Executives

Dolev RafaeliChief Executive Officer & Director
Dennis M. McGrathPresident, Chief Financial Officer & Director
Jeffrey L. LevatterChief Technology Officer
Christina L. AllgeierChief Accounting Officer
Michele PupachCorporate Counsel & Head-Investor Relations